A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

NCT07079228 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

602

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: QLS31905
DRUG: Nab-paclitaxel.
DRUG: Gemcitabine
DRUG: Placebo for QLS31905
DRUG: Nab-paclitaxel.
DRUG: Gemcitabine

Sponsor

Qilu Pharmaceutical Co., Ltd.